The Evolution of Divided Infringement Doctrine And the Potential Risk to Critical Innovation in Life Sciences

Michael Kahn co-authored “The Evolution of Divided Infringement Doctrine And the Potential Risk to Critical Innovation in Life Sciences” in the August 8, 2014, issue of Bloomberg BNA's Pharmaceutical Law & Industry Report.